Genetic factors involved in the susceptibility to drug addiction still remain largely unknown. MiRNAs seem to play key roles in the drug-induced plasticity of the brain that likely drives the emergence of addiction. In this work we explored the role of miRNAs in drug addiction. With this aim, we selected 62 SNPs located in the 3'UTR of target genes that are predicted to alter the binding of miRNA molecules and performed a case-control association study in a Spanish sample of 735 cases (mainly cocainedependent subjects with multiple drug dependencies) and 739 controls. We found an association between rs1047383 in the PLCB1 gene and drug dependence that was replicated in an independent sample (663 cases and 667 controls). Then we selected 9 miRNAs predicted to bind the rs1047383 region, but none of them showed any effect on PLCB1 expression. We also assessed two miRNAs binding a region that contains a SNP in linkage disequilibrium with rs1047383, but although one of them, hsa-miR-582, was found to downregulate PLCB1, no differences were observed between alleles. Finally, we explored the possibility that PLCB1 expression is altered by cocaine and we observed a significant upregulation of the gene in the nucleus accumbens of cocaine abusers and in human dopaminergic-like neurons after cocaine treatment. Our results, together with previous studies, suggest that PLCB1 participates in the susceptibility to drug dependence. Drug dependence is one of the major health problems worldwide. In Europe, about 25% of adults are estimated to have tried illicit drugs at some point in their lives 1. Usually drug consumers use more than one drug at the same time: for example, within the group of European individuals who consumed a psychoactive substance in the last 12 months, 33% had consumed two different substances and 10% had used three 2. This high prevalence of polydrug abuse is due to common and drug-specific genetic and environmental factors 3-5. It is well known that addictions are moderately to highly heritable (from 0.39 in the case of hallucinogens to 0.72 for cocaine), although the specific genetic risk factors involved in its predisposition remain largely unknown 6-9. Transcriptomic studies in animal and cellular models, as well as human studies in postmortem brain samples from addicted individuals, have revealed that both acute and chronic drug exposure produce epigenetic adaptations and changes in gene expression 10. Furthermore, recent studies have shown that some genes whose expression is altered by cocaine also contribute to cocaine dependence susceptibility 11, 12. MicroRNAs (miRNAs) are small regulatory noncoding RNA molecules (about 18-25 nucleotides in length) that control gene expression through direct binding to 3′untranslated regions (3′UTRs) of target mRNAs causing translational repression or mRNA degradation. One single miRNA can target and regulate hundreds of mRNAs